← Leaderboards
Jorge A Busciglio
University Of Connecticut Sch Of Med/Dnt
$5,409,393
Attributed
$11,415,427
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,415,427 · 7
By mechanism
RF1$5,948,645 · 1
R01$3,553,823 · 2
P50$994,429 · 1
R21$900,530 · 2
R13$18,000 · 1
Top collaborators
- Juan Fortea6 shared
- A Claudio Cuello5 shared
- Thomas M Wisniewski5 shared
- Katheleen Gardiner2 shared
- Jorge A Ghiso2 shared
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Breno Satler Diniz$7,057,085
- Dianqing Wu$34,657,786
- Chia-Ling Kuo$1,024,659
- Eric S Levine$7,642,454
- Peter Christian Albertsen$191,975
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainMolecularDown SyndromeNeuropathologyAffectS DiseasePathway InteractionsNeuronsAdultOxidative StressNerve DegenerationPathogenesisBrain TissueAstrocytesPathologyTrisomyLeadImpaired CognitionMitochondriaLive BirthAmyloidCellsBiological
Grant awards (27)
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$802,150
R01 · FY2025 · AG · contact PI
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$259,200
R01 · FY2025 · AG · contact PI
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$1,105,775
R01 · FY2024 · AG · contact PI
The Role of Inflammation and NGF Dysfunction in the Evolution of AlzheimerDisease Pathology in Down syndrome$563,692
RF1 · FY2020 · AG · contact PI
The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-Revision$2,124,233
RF1 · FY2019 · AG · contact PI
The Role of Inflammation and NGF Dysfunction in the Evolution of AlzheimerDisease Pathology in Down syndrome$3,260,720
RF1 · FY2018 · AG · contact PI
Combinational pharmacotherapies for neuronal abnormalities in Down syndrome$191,796
R21 · FY2016 · HD
2nd International Conference of the Trisomy 21 Research Society$18,000
R13 · FY2016 · NS · contact PI
Combinational pharmacotherapies for neuronal abnormalities in Down syndrome$245,889
R21 · FY2015 · HD
ASTROCYTE-RELATED MOLECULAR MECHANISMS UNDERLYING ALTERED NEURONAL PLASTICITY IN$224,584
P50 · FY2014 · AG · contact PI
iPSC from British and Danish dementias: new discovery tools for brain amyloidoses$202,501
R21 · FY2014 · AG
iPSC from British and Danish dementias: new discovery tools for brain amyloidoses$260,344
R21 · FY2013 · AG
ASTROCYTE-RELATED MOLECULAR MECHANISMS UNDERLYING ALTERED NEURONAL PLASTICITY IN$172,428
P50 · FY2013 · AG · contact PI
ASTROCYTE-RELATED MOLECULAR MECHANISMS UNDERLYING ALTERED NEURONAL PLASTICITY IN$44,568
P50 · FY2013 · AG · contact PI
ASTROCYTE-RELATED MOLECULAR MECHANISMS UNDERLYING ALTERED NEURONAL PLASTICITY IN$187,292
P50 · FY2012 · AG · contact PI
ASTROCYTE-RELATED MOLECULAR MECHANISMS UNDERLYING ALTERED NEURONAL PLASTICITY IN$181,859
P50 · FY2011 · AG · contact PI
ASTROCYTE-RELATED MOLECULAR MECHANISMS UNDERLYING ALTERED NEURONAL PLASTICITY IN$183,698
P50 · FY2010 · AG · contact PI
Mitochondrial Dysfunction in Down's Syndrome$50,654
R01 · FY2010 · HD · contact PI
Mitochondrial Dysfunction in Down's Syndrome$188,650
R01 · FY2009 · HD · contact PI
Mitochondrial Dysfunction in Down's Syndrome$188,650
R01 · FY2008 · HD · contact PI
Mitochondrial Dysfunction in Down's Syndrome$192,501
R01 · FY2007 · HD · contact PI
Mitochondrial Dysfunction in Down's Syndrome$198,250
R01 · FY2006 · HD · contact PI
ROLE OF ETS-2 AND SOD-1 IN DOWN SYNDROME NEUROPATHOLOGY$113,625
R01 · FY2003 · HD
ROLE OF ETS-2 AND SOD-1 IN DOWN SYNDROME NEUROPATHOLOGY$39,388
R01 · FY2003 · HD
ROLE OF ETS-2 AND SOD-1 IN DOWN SYNDROME NEUROPATHOLOGY$139,675
R01 · FY2002 · HD
ROLE OF ETS-2 AND SOD-1 IN DOWN SYNDROME NEUROPATHOLOGY$135,606
R01 · FY2001 · HD
ROLE OF ETS-2 AND SOD-1 IN DOWN SYNDROME NEUROPATHOLOGY$139,699
R01 · FY2000 · HD